The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer

por Wang, Xiao-Jing, Xiong, Ying, Ma, Ze-Biao, Xia, Jian-Chuan, Li, Yan-Fang
Publicado en Chin J Cancer (2016)

Promise of cancer stem cell vaccine

por Zhou, Li, Lu, Lin, Wicha, Max S, Chang, Alfred E, Xia, Jian-chuan, Ren, Xiubao, Li, Qiao
Publicado en Hum Vaccin Immunother (2015)

Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors

por Li, Jian-Jun, Xu, Guo-Liang, Gu, Mo-Fa, Luo, Guang-Yu, Rong, Zhang, Wu, Pei-Hong, Xia, Jian-Chuan
Publicado 2007

Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

por Zhu, Qian, Hu, Hao, Weng, De-Sheng, Zhang, Xiao-Fei, Chen, Chang-Long, Zhou, Zi-Qi, Tang, Yan, Xia, Jian-Chuan
Publicado en BMC Cancer (2017)

IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma

por Liu, Yuan, Zhao, Jing-Jing, Zhou, Zi-Qi, Pan, Qiu-Zhong, Zhu, Qian, Tang, Yan, Xia, Jian-Chuan, Weng, De-Sheng
Publicado en Cancer Manag Res (2019)

The Roles of Ubiquitination Factor E4B (UBE4B) in the Postoperative Prognosis of Patients with Renal Cell Carcinoma and in Renal Tumor Cells Growth and Metastasis

por Huang, Xu-Qiong, Hao, Shuai, Zhou, Zi-Qi, Huang, Bin, Fang, Jia-Ying, Tang, Yan, Zhang, Jian-Hua, Xia, Jian-Chuan
Publicado en Onco Targets Ther (2020)

The changes of CD4+CD25+/CD4+ proportion in spleen of tumor-bearing BALB/c mice

por Liu, Ji-Yan, Zhang, Xiao-Shi, Ding, Ya, Peng, Rui-Qing, Cheng, Xia, Zhang, Nian-Hua, Xia, Jian-Chuan, Zeng, Yi-Xin
Publicado 2005

Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma

por Ma, Hai-Qing, Liang, Xiao-Ting, Zhao, Jing-Jing, Wang, Hui, Sun, Jian-Cong, Chen, Yi-Bing, Pan, Ke, Xia, Jian-Chuan
Publicado 2009

Overexpression of SMOC2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma

por Huang, Xu-Qiong, Zhou, Zi-Qi, Zhang, Xiao-Fei, Chen, Chang-Long, Tang, Yan, Zhu, Qian, Zhang, Jian-Hua, Xia, Jian-Chuan
Publicado en J Cancer (2017)

Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells

por Zhao, Jing-Jing, Pan, Ke, Wang, Qi-Jing, Xu, Zheng-Di, Weng, De-Sheng, Li, Jian-Jun, Li, Yong-Qiang, Xia, Jian-Chuan
Publicado 2013

Characterization of a Novel Transgenic Mouse Tumor Model for Targeting HER2+ Cancer Stem Cells

por Wang, Su He, Lu, Lin, Fan, Yongyi, Wicha, Max S., Cao, Zhengyi, Chang, Alfred E., Xia, Jian-chuan, Baker Jr., James R., Li, Qiao
Publicado 2013

Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma

por Li, Yin, Pan, Ke, Liu, Li-zhi, Li, Yong-qiang, Gu, Mo-fa, Zhang, Hua, Shen, Wei-xi, Xia, Jian-chuan, Li, Jian-jun
Publicado en PLoS One (2015)

PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

por Zhou, Zi-Qi, Zhao, Jing-Jing, Pan, Qiu-Zhong, Chen, Chang-Long, Liu, Yuan, Tang, Yan, Zhu, Qian, Weng, De-Sheng, Xia, Jian-Chuan
Publicado en J Immunother Cancer (2019)

High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients

por Sun, Jian-Cong, Liang, Xiao-Ting, Pan, Ke, Wang, Hui, Zhao, Jing-Jing, Li, Jian-Jun, Ma, Hai-Qing, Chen, Yi-Bing, Xia, Jian-Chuan
Publicado 2010

Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma

por Li, Jian-Jun, Pan, Ke, Gu, Mo-Fa, Chen, Min-Shan, Zhao, Jing-Jing, Wang, Hui, Liang, Xiao-Ting, Sun, Jian-Cong, Xia, Jian-Chuan
Publicado 2013

Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients

por Jiang, Shan-Shan, Jiang, Long, Weng, De-Sheng, Li, Yuan-fang, Pan, Qiu-Zhong, Zhao, Jing-Jing, Tang, Yan, Zhou, Zhi-Wei, Xia, Jian-Chuan
Publicado en J Cancer (2017)

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy

por Zhou, Yun, Chen, Chang-long, Jiang, Sen-wei, Feng, Yanling, Yuan, Linjing, Chen, Ping, Zhang, Lan, Huang, Shuting, Li, Jundong, Xia, Jian-Chuan, Zheng, Min
Publicado en Oncoimmunology (2018)

Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes

por Zhu, Qian, Cai, Mu-Yan, Chen, Chang-Long, Hu, Hao, Lin, Huan-Xin, Li, Min, Weng, De-Sheng, Zhao, Jing-Jing, Guo, Ling, Xia, Jian-Chuan
Publicado en Oncoimmunology (2017)

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma

por Zhao, Jing-Jing, Zhou, Zi-Qi, Wang, Peng, Chen, Chang-Long, Liu, Yuan, Pan, Qiu-Zhong, Zhu, Qian, Tang, Yan, Weng, De-Sheng, Xia, Jian-Chuan
Publicado en Cancer Manag Res (2018)

PD-L1 expression patterns in tumour cells and their association with CD8(+) tumour infiltrating lymphocytes in clear cell renal cell carcinoma

por Zhu, Qian, Cai, Mu-Yan, Weng, De-Sheng, Zhao, Jing-Jing, Pan, Qiu-Zhong, Wang, Qi-Jing, Tang, Yan, He, Jia, Li, Min, Xia, Jian-Chuan
Publicado en J Cancer (2019)